Craft

Huma

Market Valuation

$300 M

2019-11-05

Total Funding

$184 M

Revenue

£5.3 M

FY, 2021

Huma Summary

Company Summary

Overview
Huma Therapeutics (formerly known as Medopad) is a health-tech company that provides remote patient monitoring platforms for patients and accelerates research and therapies. It offers telemedicine and appointments, individual patient monitoring, eligibility screening and onboarding, participant-level monitoring, and other solutions. The company caters to the healthcare, insurance, pharmaceutical, and technology sectors.
Type
Private
Status
Active
Founded
2011
HQ
London, GB | view all locations
Website
https://huma.com
Cybersecurity rating
Sectors

Key People

Operating MetricsView all

Solutions

3

Nov, 2022

Trademarks

3

Nov, 2022

Trademark Applications

1

Nov, 2022

LocationsView all

4 locations detected

  • London, England HQ

    United Kingdom

    13th floor, Millbank Tower, 21-24 Millbank

  • New York, NY

    United States

    101 6th Ave

  • Shanghai, Shang Hai Shi

    China

    Room 123, 13th Floor Shanghai Tower No. 501 Yincheng Middle Road

  • Hamburg, HH

    Germany

    Raboisen 32

Huma Financials

Summary Financials

Revenue (FY, 2021)
£5.3M
Gross profit (FY, 2021)
£4.7M
Net income (FY, 2021)
(£25.8M)
Cash (FY, 2021)
£45.9M
EBIT (FY, 2021)
(£27.3M)
Enterprise value
$254.1M

Footer menu